Hypomethylating agents for the treatment of acute myeloid leukemia in the elderly: for all, none, or which patients? [electronic resource]
- Cancer Sep 2011
- 3879-81 p. digital
Publication Type: Editorial
1097-0142
10.1002/cncr.25934 doi
Aged Antineoplastic Agents--therapeutic use Azacitidine--administration & dosage Clinical Trials as Topic DNA Methylation DNA Modification Methylases--antagonists & inhibitors Decitabine Humans Leukemia, Myeloid, Acute--drug therapy Middle Aged Treatment Outcome